nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—DRD4—obesity	0.0661	0.168	CbGaD
Cabergoline—HTR1B—obesity	0.0587	0.149	CbGaD
Cabergoline—DRD1—obesity	0.056	0.142	CbGaD
Cabergoline—ADRB1—obesity	0.0519	0.132	CbGaD
Cabergoline—HTR2C—obesity	0.0479	0.121	CbGaD
Cabergoline—ADRB2—obesity	0.0437	0.111	CbGaD
Cabergoline—ADRA1B—Phendimetrazine—obesity	0.0402	0.108	CbGbCtD
Cabergoline—DRD2—obesity	0.0394	0.1	CbGaD
Cabergoline—DRD1—Phenylpropanolamine—obesity	0.0362	0.0974	CbGbCtD
Cabergoline—ADRB2—Phenylpropanolamine—obesity	0.0317	0.0852	CbGbCtD
Cabergoline—ADRA1A—Phendimetrazine—obesity	0.0317	0.0852	CbGbCtD
Cabergoline—ADRB1—Phenylpropanolamine—obesity	0.0312	0.0839	CbGbCtD
Cabergoline—HTR2A—obesity	0.0305	0.0773	CbGaD
Cabergoline—ADRA2C—Methamphetamine—obesity	0.0303	0.0816	CbGbCtD
Cabergoline—ADRA2B—Methamphetamine—obesity	0.0288	0.0774	CbGbCtD
Cabergoline—ADRA2A—Benzphetamine—obesity	0.025	0.0674	CbGbCtD
Cabergoline—ADRA1A—Benzphetamine—obesity	0.024	0.0646	CbGbCtD
Cabergoline—ADRA2A—Phenylpropanolamine—obesity	0.0239	0.0643	CbGbCtD
Cabergoline—ADRA1A—Phenylpropanolamine—obesity	0.0229	0.0616	CbGbCtD
Cabergoline—ADRA2A—Methamphetamine—obesity	0.02	0.0538	CbGbCtD
Cabergoline—CYP3A4—Sibutramine—obesity	0.00699	0.0188	CbGbCtD
Cabergoline—CYP3A4—Benzphetamine—obesity	0.0053	0.0142	CbGbCtD
Cabergoline—CYP3A4—Bupropion—obesity	0.0045	0.0121	CbGbCtD
Cabergoline—CYP3A4—Orlistat—obesity	0.00367	0.00987	CbGbCtD
Cabergoline—CYP3A4—Cimetidine—obesity	0.00331	0.00889	CbGbCtD
Cabergoline—CYP3A4—Topiramate—obesity	0.00216	0.00582	CbGbCtD
Cabergoline—HTR7—sympathetic nervous system—obesity	0.00189	0.0905	CbGeAlD
Cabergoline—HTR7—vagus nerve—obesity	0.00183	0.0876	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—obesity	0.00127	0.0608	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—obesity	0.00118	0.0564	CbGeAlD
Cabergoline—HTR2A—vagus nerve—obesity	0.00114	0.0546	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—obesity	0.000792	0.0379	CbGeAlD
Cabergoline—HTR1A—hindbrain—obesity	0.00056	0.0268	CbGeAlD
Cabergoline—HTR7—hindbrain—obesity	0.000535	0.0256	CbGeAlD
Cabergoline—ADRA1A—hindbrain—obesity	0.000516	0.0247	CbGeAlD
Cabergoline—DRD2—hindbrain—obesity	0.000506	0.0242	CbGeAlD
Cabergoline—DRD5—endocrine gland—obesity	0.00036	0.0172	CbGeAlD
Cabergoline—Pergolide—DRD4—obesity	0.000341	0.11	CrCbGaD
Cabergoline—HTR2A—hindbrain—obesity	0.000334	0.016	CbGeAlD
Cabergoline—HTR7—respiratory system—obesity	0.000327	0.0156	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—obesity	0.000325	0.0155	CbGeAlD
Cabergoline—HTR2B—adrenal cortex—obesity	0.00032	0.0153	CbGeAlD
Cabergoline—HTR1D—cardiovascular system—obesity	0.000314	0.015	CbGeAlD
Cabergoline—DRD2—respiratory system—obesity	0.000309	0.0148	CbGeAlD
Cabergoline—ADRB1—cardiovascular system—obesity	0.000305	0.0146	CbGeAlD
Cabergoline—Pergolide—HTR1B—obesity	0.000303	0.0974	CrCbGaD
Cabergoline—Lisuride—DRD4—obesity	0.000296	0.0952	CrCbGaD
Cabergoline—HTR2B—cardiovascular system—obesity	0.000292	0.014	CbGeAlD
Cabergoline—Pergolide—DRD1—obesity	0.000289	0.0929	CrCbGaD
Cabergoline—ADRA1D—endocrine gland—obesity	0.000288	0.0138	CbGeAlD
Cabergoline—ADRB1—adipose tissue—obesity	0.000269	0.0129	CbGeAlD
Cabergoline—Lisuride—HTR1B—obesity	0.000263	0.0846	CrCbGaD
Cabergoline—HTR1A—cardiovascular system—obesity	0.000262	0.0125	CbGeAlD
Cabergoline—HTR2B—adipose tissue—obesity	0.000258	0.0123	CbGeAlD
Cabergoline—ADRA2A—islet of Langerhans—obesity	0.000254	0.0122	CbGeAlD
Cabergoline—ADRA2C—adrenal cortex—obesity	0.000252	0.0121	CbGeAlD
Cabergoline—Lisuride—DRD1—obesity	0.000251	0.0806	CrCbGaD
Cabergoline—HTR7—cardiovascular system—obesity	0.00025	0.012	CbGeAlD
Cabergoline—Pergolide—HTR2C—obesity	0.000247	0.0794	CrCbGaD
Cabergoline—HTR2B—digestive system—obesity	0.000243	0.0116	CbGeAlD
Cabergoline—ADRA1A—cardiovascular system—obesity	0.000242	0.0116	CbGeAlD
Cabergoline—Lisuride—ADRB1—obesity	0.000233	0.0748	CrCbGaD
Cabergoline—HTR2B—adrenal gland—obesity	0.000231	0.0111	CbGeAlD
Cabergoline—HTR1B—endocrine gland—obesity	0.000223	0.0107	CbGeAlD
Cabergoline—Lisuride—HTR2C—obesity	0.000214	0.0689	CrCbGaD
Cabergoline—ADRA1A—adipose tissue—obesity	0.000213	0.0102	CbGeAlD
Cabergoline—DRD2—pituitary gland—obesity	0.00021	0.01	CbGeAlD
Cabergoline—ADRB1—endocrine gland—obesity	0.00021	0.01	CbGeAlD
Cabergoline—HTR7—digestive system—obesity	0.000208	0.00995	CbGeAlD
Cabergoline—HTR1A—adrenal gland—obesity	0.000207	0.00992	CbGeAlD
Cabergoline—HTR2A—respiratory system—obesity	0.000204	0.00976	CbGeAlD
Cabergoline—ADRA2C—pituitary gland—obesity	0.000204	0.00975	CbGeAlD
Cabergoline—Pergolide—DRD2—obesity	0.000204	0.0655	CrCbGaD
Cabergoline—ADRA2C—adipose tissue—obesity	0.000203	0.00971	CbGeAlD
Cabergoline—HTR7—adrenal gland—obesity	0.000198	0.00948	CbGeAlD
Cabergoline—ADRA1A—adrenal gland—obesity	0.000191	0.00914	CbGeAlD
Cabergoline—ADRA2C—adrenal gland—obesity	0.000182	0.00871	CbGeAlD
Cabergoline—HTR1A—endocrine gland—obesity	0.00018	0.0086	CbGeAlD
Cabergoline—Lisuride—DRD2—obesity	0.000177	0.0568	CrCbGaD
Cabergoline—HTR7—endocrine gland—obesity	0.000172	0.00822	CbGeAlD
Cabergoline—ADRA1A—endocrine gland—obesity	0.000166	0.00793	CbGeAlD
Cabergoline—Influenza like illness—Topiramate—obesity	0.000165	0.00157	CcSEcCtD
Cabergoline—Vomiting—Phenylpropanolamine—obesity	0.000164	0.00156	CcSEcCtD
Cabergoline—Dizziness—Phentermine—obesity	0.000163	0.00156	CcSEcCtD
Cabergoline—Sweating increased—Bupropion—obesity	0.000163	0.00156	CcSEcCtD
Cabergoline—ADRA2A—pituitary gland—obesity	0.000163	0.00778	CbGeAlD
Cabergoline—DRD2—endocrine gland—obesity	0.000162	0.00777	CbGeAlD
Cabergoline—Rash—Phenylpropanolamine—obesity	0.000162	0.00155	CcSEcCtD
Cabergoline—Dermatitis—Phenylpropanolamine—obesity	0.000162	0.00155	CcSEcCtD
Cabergoline—ADRA2A—adipose tissue—obesity	0.000162	0.00775	CbGeAlD
Cabergoline—Epistaxis—Sibutramine—obesity	0.000161	0.00154	CcSEcCtD
Cabergoline—Bronchitis—Bupropion—obesity	0.000161	0.00154	CcSEcCtD
Cabergoline—Abdominal discomfort—Bupropion—obesity	0.00016	0.00153	CcSEcCtD
Cabergoline—Pergolide—HTR2A—obesity	0.000157	0.0506	CrCbGaD
Cabergoline—Vomiting—Phentermine—obesity	0.000157	0.0015	CcSEcCtD
Cabergoline—Oedema peripheral—Orlistat—obesity	0.000156	0.00149	CcSEcCtD
Cabergoline—HTR2A—cardiovascular system—obesity	0.000156	0.00747	CbGeAlD
Cabergoline—Cramps of lower extremities—Topiramate—obesity	0.000156	0.00149	CcSEcCtD
Cabergoline—Rash—Phentermine—obesity	0.000155	0.00148	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Bupropion—obesity	0.000155	0.00148	CcSEcCtD
Cabergoline—Dermatitis—Phentermine—obesity	0.000155	0.00148	CcSEcCtD
Cabergoline—HTR7—liver—obesity	0.000155	0.00741	CbGeAlD
Cabergoline—Headache—Phentermine—obesity	0.000154	0.00147	CcSEcCtD
Cabergoline—Rhinitis—Sibutramine—obesity	0.000154	0.00147	CcSEcCtD
Cabergoline—Nausea—Phenylpropanolamine—obesity	0.000153	0.00146	CcSEcCtD
Cabergoline—Weight increased—Bupropion—obesity	0.000152	0.00145	CcSEcCtD
Cabergoline—Weight decreased—Bupropion—obesity	0.000151	0.00144	CcSEcCtD
Cabergoline—Oedema peripheral—Sibutramine—obesity	0.000151	0.00144	CcSEcCtD
Cabergoline—Hypersensitivity—Cimetidine—obesity	0.00015	0.00144	CcSEcCtD
Cabergoline—Pneumonia—Bupropion—obesity	0.00015	0.00143	CcSEcCtD
Cabergoline—ADRA1A—liver—obesity	0.000149	0.00715	CbGeAlD
Cabergoline—Abnormal vision—Topiramate—obesity	0.000148	0.00141	CcSEcCtD
Cabergoline—Visual impairment—Sibutramine—obesity	0.000148	0.00141	CcSEcCtD
Cabergoline—Mental disability—Topiramate—obesity	0.000147	0.00141	CcSEcCtD
Cabergoline—Diarrhoea—Diethylpropion—obesity	0.000147	0.0014	CcSEcCtD
Cabergoline—Nausea—Phentermine—obesity	0.000146	0.0014	CcSEcCtD
Cabergoline—Asthenia—Cimetidine—obesity	0.000146	0.0014	CcSEcCtD
Cabergoline—Euphoric mood—Topiramate—obesity	0.000146	0.00139	CcSEcCtD
Cabergoline—ADRA2A—adrenal gland—obesity	0.000145	0.00695	CbGeAlD
Cabergoline—Urinary tract infection—Bupropion—obesity	0.000145	0.00138	CcSEcCtD
Cabergoline—ADRA2C—liver—obesity	0.000142	0.00681	CbGeAlD
Cabergoline—Sleep disorder—Topiramate—obesity	0.000142	0.00136	CcSEcCtD
Cabergoline—Dizziness—Diethylpropion—obesity	0.000142	0.00135	CcSEcCtD
Cabergoline—Epistaxis—Bupropion—obesity	0.000141	0.00134	CcSEcCtD
Cabergoline—Alopecia—Orlistat—obesity	0.00014	0.00134	CcSEcCtD
Cabergoline—Diarrhoea—Cimetidine—obesity	0.00014	0.00133	CcSEcCtD
Cabergoline—HTR2A—pituitary gland—obesity	0.000138	0.00662	CbGeAlD
Cabergoline—Arrhythmia—Sibutramine—obesity	0.000137	0.00131	CcSEcCtD
Cabergoline—Lisuride—HTR2A—obesity	0.000137	0.0439	CrCbGaD
Cabergoline—Vomiting—Diethylpropion—obesity	0.000136	0.0013	CcSEcCtD
Cabergoline—Flatulence—Orlistat—obesity	0.000136	0.0013	CcSEcCtD
Cabergoline—Alopecia—Sibutramine—obesity	0.000136	0.0013	CcSEcCtD
Cabergoline—Nasal congestion—Topiramate—obesity	0.000135	0.00129	CcSEcCtD
Cabergoline—Rash—Diethylpropion—obesity	0.000135	0.00129	CcSEcCtD
Cabergoline—Dermatitis—Diethylpropion—obesity	0.000135	0.00129	CcSEcCtD
Cabergoline—Dizziness—Cimetidine—obesity	0.000135	0.00129	CcSEcCtD
Cabergoline—Headache—Diethylpropion—obesity	0.000134	0.00128	CcSEcCtD
Cabergoline—Rhinitis—Bupropion—obesity	0.000134	0.00128	CcSEcCtD
Cabergoline—Back pain—Orlistat—obesity	0.000133	0.00128	CcSEcCtD
Cabergoline—Hallucination—Bupropion—obesity	0.000133	0.00127	CcSEcCtD
Cabergoline—Muscle spasms—Orlistat—obesity	0.000133	0.00127	CcSEcCtD
Cabergoline—Oedema peripheral—Bupropion—obesity	0.000132	0.00126	CcSEcCtD
Cabergoline—Hot flush—Topiramate—obesity	0.000132	0.00126	CcSEcCtD
Cabergoline—Flatulence—Sibutramine—obesity	0.000132	0.00126	CcSEcCtD
Cabergoline—Tension—Sibutramine—obesity	0.000131	0.00125	CcSEcCtD
Cabergoline—Menopausal symptoms—Topiramate—obesity	0.000131	0.00125	CcSEcCtD
Cabergoline—Nervousness—Sibutramine—obesity	0.00013	0.00124	CcSEcCtD
Cabergoline—Vomiting—Cimetidine—obesity	0.00013	0.00124	CcSEcCtD
Cabergoline—HTR2A—digestive system—obesity	0.00013	0.0062	CbGeAlD
Cabergoline—Back pain—Sibutramine—obesity	0.000129	0.00123	CcSEcCtD
Cabergoline—Visual impairment—Bupropion—obesity	0.000129	0.00123	CcSEcCtD
Cabergoline—Rash—Cimetidine—obesity	0.000129	0.00123	CcSEcCtD
Cabergoline—Dermatitis—Cimetidine—obesity	0.000128	0.00123	CcSEcCtD
Cabergoline—Muscle spasms—Sibutramine—obesity	0.000128	0.00123	CcSEcCtD
Cabergoline—Ill-defined disorder—Orlistat—obesity	0.000128	0.00122	CcSEcCtD
Cabergoline—Headache—Cimetidine—obesity	0.000128	0.00122	CcSEcCtD
Cabergoline—Nausea—Diethylpropion—obesity	0.000127	0.00122	CcSEcCtD
Cabergoline—ADRA2A—endocrine gland—obesity	0.000126	0.00603	CbGeAlD
Cabergoline—Malaise—Orlistat—obesity	0.000124	0.00119	CcSEcCtD
Cabergoline—Cardiac disorder—Bupropion—obesity	0.000124	0.00119	CcSEcCtD
Cabergoline—Vertigo—Orlistat—obesity	0.000124	0.00118	CcSEcCtD
Cabergoline—Ill-defined disorder—Sibutramine—obesity	0.000124	0.00118	CcSEcCtD
Cabergoline—HTR2A—adrenal gland—obesity	0.000124	0.00591	CbGeAlD
Cabergoline—Osteoarthritis—Topiramate—obesity	0.000123	0.00118	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Topiramate—obesity	0.000122	0.00117	CcSEcCtD
Cabergoline—Palpitations—Orlistat—obesity	0.000122	0.00117	CcSEcCtD
Cabergoline—Nausea—Cimetidine—obesity	0.000121	0.00116	CcSEcCtD
Cabergoline—Malaise—Sibutramine—obesity	0.00012	0.00115	CcSEcCtD
Cabergoline—Psychotic disorder—Topiramate—obesity	0.00012	0.00115	CcSEcCtD
Cabergoline—CYP3A4—digestive system—obesity	0.00012	0.00574	CbGeAlD
Cabergoline—Vertigo—Sibutramine—obesity	0.00012	0.00115	CcSEcCtD
Cabergoline—Syncope—Sibutramine—obesity	0.00012	0.00114	CcSEcCtD
Cabergoline—Arrhythmia—Bupropion—obesity	0.000119	0.00114	CcSEcCtD
Cabergoline—Face oedema—Topiramate—obesity	0.000119	0.00114	CcSEcCtD
Cabergoline—Alopecia—Bupropion—obesity	0.000118	0.00113	CcSEcCtD
Cabergoline—Palpitations—Sibutramine—obesity	0.000118	0.00113	CcSEcCtD
Cabergoline—Loss of consciousness—Sibutramine—obesity	0.000117	0.00112	CcSEcCtD
Cabergoline—Anxiety—Orlistat—obesity	0.000117	0.00112	CcSEcCtD
Cabergoline—Discomfort—Orlistat—obesity	0.000116	0.00111	CcSEcCtD
Cabergoline—Blood creatinine increased—Topiramate—obesity	0.000115	0.0011	CcSEcCtD
Cabergoline—Hypertension—Sibutramine—obesity	0.000115	0.0011	CcSEcCtD
Cabergoline—Dry mouth—Orlistat—obesity	0.000115	0.0011	CcSEcCtD
Cabergoline—Flatulence—Bupropion—obesity	0.000115	0.0011	CcSEcCtD
Cabergoline—Tension—Bupropion—obesity	0.000114	0.00109	CcSEcCtD
Cabergoline—Liver function test abnormal—Topiramate—obesity	0.000114	0.00109	CcSEcCtD
Cabergoline—Arthralgia—Sibutramine—obesity	0.000114	0.00109	CcSEcCtD
Cabergoline—Anxiety—Sibutramine—obesity	0.000113	0.00108	CcSEcCtD
Cabergoline—Nervousness—Bupropion—obesity	0.000113	0.00108	CcSEcCtD
Cabergoline—Oedema—Orlistat—obesity	0.000113	0.00108	CcSEcCtD
Cabergoline—Back pain—Bupropion—obesity	0.000113	0.00108	CcSEcCtD
Cabergoline—Abdominal pain upper—Topiramate—obesity	0.000112	0.00107	CcSEcCtD
Cabergoline—Orthostatic hypotension—Topiramate—obesity	0.000112	0.00107	CcSEcCtD
Cabergoline—Discomfort—Sibutramine—obesity	0.000112	0.00107	CcSEcCtD
Cabergoline—Muscle spasms—Bupropion—obesity	0.000112	0.00107	CcSEcCtD
Cabergoline—Dry mouth—Sibutramine—obesity	0.000111	0.00106	CcSEcCtD
Cabergoline—Confusional state—Sibutramine—obesity	0.00011	0.00105	CcSEcCtD
Cabergoline—Gastritis—Topiramate—obesity	0.000109	0.00104	CcSEcCtD
Cabergoline—Oedema—Sibutramine—obesity	0.000109	0.00104	CcSEcCtD
Cabergoline—Hyperhidrosis—Orlistat—obesity	0.000109	0.00104	CcSEcCtD
Cabergoline—Ill-defined disorder—Bupropion—obesity	0.000108	0.00103	CcSEcCtD
Cabergoline—Shock—Sibutramine—obesity	0.000107	0.00102	CcSEcCtD
Cabergoline—HTR2A—endocrine gland—obesity	0.000107	0.00513	CbGeAlD
Cabergoline—Hyperhidrosis—Sibutramine—obesity	0.000105	0.00101	CcSEcCtD
Cabergoline—Malaise—Bupropion—obesity	0.000105	0.001	CcSEcCtD
Cabergoline—Vertigo—Bupropion—obesity	0.000105	0.000999	CcSEcCtD
Cabergoline—Syncope—Bupropion—obesity	0.000104	0.000997	CcSEcCtD
Cabergoline—Anorexia—Sibutramine—obesity	0.000104	0.000993	CcSEcCtD
Cabergoline—Sweating increased—Topiramate—obesity	0.000104	0.000991	CcSEcCtD
Cabergoline—Palpitations—Bupropion—obesity	0.000103	0.000983	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Orlistat—obesity	0.000103	0.00098	CcSEcCtD
Cabergoline—Bronchitis—Topiramate—obesity	0.000102	0.000978	CcSEcCtD
Cabergoline—Loss of consciousness—Bupropion—obesity	0.000102	0.000978	CcSEcCtD
Cabergoline—Abdominal discomfort—Topiramate—obesity	0.000102	0.000975	CcSEcCtD
Cabergoline—Insomnia—Orlistat—obesity	0.000102	0.000973	CcSEcCtD
Cabergoline—Hypotension—Sibutramine—obesity	0.000102	0.000973	CcSEcCtD
Cabergoline—Paraesthesia—Orlistat—obesity	0.000101	0.000966	CcSEcCtD
Cabergoline—Hypertension—Bupropion—obesity	0.000101	0.00096	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Sibutramine—obesity	9.93e-05	0.000949	CcSEcCtD
Cabergoline—CYP3A4—endocrine gland—obesity	9.92e-05	0.00475	CbGeAlD
Cabergoline—Dyspepsia—Orlistat—obesity	9.91e-05	0.000947	CcSEcCtD
Cabergoline—Arthralgia—Bupropion—obesity	9.91e-05	0.000947	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Topiramate—obesity	9.89e-05	0.000945	CcSEcCtD
Cabergoline—Anxiety—Bupropion—obesity	9.88e-05	0.000944	CcSEcCtD
Cabergoline—Insomnia—Sibutramine—obesity	9.86e-05	0.000942	CcSEcCtD
Cabergoline—Discomfort—Bupropion—obesity	9.79e-05	0.000936	CcSEcCtD
Cabergoline—Decreased appetite—Orlistat—obesity	9.79e-05	0.000935	CcSEcCtD
Cabergoline—Paraesthesia—Sibutramine—obesity	9.79e-05	0.000935	CcSEcCtD
Cabergoline—Dyspnoea—Sibutramine—obesity	9.72e-05	0.000928	CcSEcCtD
Cabergoline—Fatigue—Orlistat—obesity	9.71e-05	0.000928	CcSEcCtD
Cabergoline—Dry mouth—Bupropion—obesity	9.69e-05	0.000926	CcSEcCtD
Cabergoline—Somnolence—Sibutramine—obesity	9.69e-05	0.000926	CcSEcCtD
Cabergoline—Weight increased—Topiramate—obesity	9.69e-05	0.000926	CcSEcCtD
Cabergoline—HTR2A—liver—obesity	9.66e-05	0.00462	CbGeAlD
Cabergoline—Weight decreased—Topiramate—obesity	9.63e-05	0.00092	CcSEcCtD
Cabergoline—Pain—Orlistat—obesity	9.63e-05	0.00092	CcSEcCtD
Cabergoline—Dyspepsia—Sibutramine—obesity	9.59e-05	0.000917	CcSEcCtD
Cabergoline—Confusional state—Bupropion—obesity	9.58e-05	0.000915	CcSEcCtD
Cabergoline—Pneumonia—Topiramate—obesity	9.55e-05	0.000912	CcSEcCtD
Cabergoline—Oedema—Bupropion—obesity	9.5e-05	0.000908	CcSEcCtD
Cabergoline—Decreased appetite—Sibutramine—obesity	9.47e-05	0.000905	CcSEcCtD
Cabergoline—Depression—Topiramate—obesity	9.46e-05	0.000904	CcSEcCtD
Cabergoline—Shock—Bupropion—obesity	9.35e-05	0.000893	CcSEcCtD
Cabergoline—Constipation—Sibutramine—obesity	9.32e-05	0.00089	CcSEcCtD
Cabergoline—Pain—Sibutramine—obesity	9.32e-05	0.00089	CcSEcCtD
Cabergoline—Feeling abnormal—Orlistat—obesity	9.28e-05	0.000887	CcSEcCtD
Cabergoline—Urinary tract infection—Topiramate—obesity	9.23e-05	0.000881	CcSEcCtD
Cabergoline—Gastrointestinal pain—Orlistat—obesity	9.21e-05	0.00088	CcSEcCtD
Cabergoline—Hyperhidrosis—Bupropion—obesity	9.19e-05	0.000878	CcSEcCtD
Cabergoline—Anorexia—Bupropion—obesity	9.06e-05	0.000865	CcSEcCtD
Cabergoline—Feeling abnormal—Sibutramine—obesity	8.98e-05	0.000858	CcSEcCtD
Cabergoline—Epistaxis—Topiramate—obesity	8.95e-05	0.000855	CcSEcCtD
Cabergoline—CYP3A4—liver—obesity	8.94e-05	0.00428	CbGeAlD
Cabergoline—Gastrointestinal pain—Sibutramine—obesity	8.91e-05	0.000851	CcSEcCtD
Cabergoline—Abdominal pain—Orlistat—obesity	8.9e-05	0.000851	CcSEcCtD
Cabergoline—Hypotension—Bupropion—obesity	8.88e-05	0.000848	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Bupropion—obesity	8.66e-05	0.000827	CcSEcCtD
Cabergoline—Abdominal pain—Sibutramine—obesity	8.62e-05	0.000823	CcSEcCtD
Cabergoline—Insomnia—Bupropion—obesity	8.59e-05	0.000821	CcSEcCtD
Cabergoline—Rhinitis—Topiramate—obesity	8.54e-05	0.000816	CcSEcCtD
Cabergoline—Paraesthesia—Bupropion—obesity	8.53e-05	0.000815	CcSEcCtD
Cabergoline—Hallucination—Topiramate—obesity	8.48e-05	0.00081	CcSEcCtD
Cabergoline—Dyspnoea—Bupropion—obesity	8.47e-05	0.000809	CcSEcCtD
Cabergoline—Somnolence—Bupropion—obesity	8.45e-05	0.000807	CcSEcCtD
Cabergoline—Oedema peripheral—Topiramate—obesity	8.39e-05	0.000802	CcSEcCtD
Cabergoline—Dyspepsia—Bupropion—obesity	8.36e-05	0.000799	CcSEcCtD
Cabergoline—Hypersensitivity—Orlistat—obesity	8.3e-05	0.000793	CcSEcCtD
Cabergoline—Decreased appetite—Bupropion—obesity	8.26e-05	0.000789	CcSEcCtD
Cabergoline—Visual impairment—Topiramate—obesity	8.21e-05	0.000785	CcSEcCtD
Cabergoline—Fatigue—Bupropion—obesity	8.19e-05	0.000783	CcSEcCtD
Cabergoline—Pain—Bupropion—obesity	8.13e-05	0.000776	CcSEcCtD
Cabergoline—Constipation—Bupropion—obesity	8.13e-05	0.000776	CcSEcCtD
Cabergoline—Asthenia—Orlistat—obesity	8.08e-05	0.000772	CcSEcCtD
Cabergoline—Hypersensitivity—Sibutramine—obesity	8.03e-05	0.000767	CcSEcCtD
Cabergoline—Pruritus—Orlistat—obesity	7.97e-05	0.000761	CcSEcCtD
Cabergoline—Cardiac disorder—Topiramate—obesity	7.91e-05	0.000756	CcSEcCtD
Cabergoline—Feeling abnormal—Bupropion—obesity	7.83e-05	0.000748	CcSEcCtD
Cabergoline—Asthenia—Sibutramine—obesity	7.82e-05	0.000747	CcSEcCtD
Cabergoline—Gastrointestinal pain—Bupropion—obesity	7.77e-05	0.000742	CcSEcCtD
Cabergoline—Pruritus—Sibutramine—obesity	7.71e-05	0.000737	CcSEcCtD
Cabergoline—Diarrhoea—Orlistat—obesity	7.71e-05	0.000736	CcSEcCtD
Cabergoline—Alopecia—Topiramate—obesity	7.53e-05	0.000719	CcSEcCtD
Cabergoline—Abdominal pain—Bupropion—obesity	7.51e-05	0.000718	CcSEcCtD
Cabergoline—Diarrhoea—Sibutramine—obesity	7.46e-05	0.000712	CcSEcCtD
Cabergoline—Dizziness—Orlistat—obesity	7.45e-05	0.000712	CcSEcCtD
Cabergoline—Flatulence—Topiramate—obesity	7.31e-05	0.000698	CcSEcCtD
Cabergoline—Tension—Topiramate—obesity	7.28e-05	0.000695	CcSEcCtD
Cabergoline—Dizziness—Sibutramine—obesity	7.21e-05	0.000689	CcSEcCtD
Cabergoline—Nervousness—Topiramate—obesity	7.2e-05	0.000688	CcSEcCtD
Cabergoline—Back pain—Topiramate—obesity	7.17e-05	0.000685	CcSEcCtD
Cabergoline—Vomiting—Orlistat—obesity	7.16e-05	0.000684	CcSEcCtD
Cabergoline—Muscle spasms—Topiramate—obesity	7.13e-05	0.000681	CcSEcCtD
Cabergoline—Rash—Orlistat—obesity	7.1e-05	0.000678	CcSEcCtD
Cabergoline—Dermatitis—Orlistat—obesity	7.09e-05	0.000678	CcSEcCtD
Cabergoline—Headache—Orlistat—obesity	7.05e-05	0.000674	CcSEcCtD
Cabergoline—Hypersensitivity—Bupropion—obesity	7e-05	0.000669	CcSEcCtD
Cabergoline—Vomiting—Sibutramine—obesity	6.93e-05	0.000662	CcSEcCtD
Cabergoline—Ill-defined disorder—Topiramate—obesity	6.88e-05	0.000658	CcSEcCtD
Cabergoline—Rash—Sibutramine—obesity	6.87e-05	0.000657	CcSEcCtD
Cabergoline—Dermatitis—Sibutramine—obesity	6.87e-05	0.000656	CcSEcCtD
Cabergoline—Headache—Sibutramine—obesity	6.83e-05	0.000652	CcSEcCtD
Cabergoline—Asthenia—Bupropion—obesity	6.82e-05	0.000651	CcSEcCtD
Cabergoline—Pruritus—Bupropion—obesity	6.72e-05	0.000642	CcSEcCtD
Cabergoline—Nausea—Orlistat—obesity	6.69e-05	0.000639	CcSEcCtD
Cabergoline—Malaise—Topiramate—obesity	6.69e-05	0.000639	CcSEcCtD
Cabergoline—Vertigo—Topiramate—obesity	6.66e-05	0.000637	CcSEcCtD
Cabergoline—Syncope—Topiramate—obesity	6.65e-05	0.000636	CcSEcCtD
Cabergoline—Palpitations—Topiramate—obesity	6.55e-05	0.000626	CcSEcCtD
Cabergoline—Loss of consciousness—Topiramate—obesity	6.52e-05	0.000623	CcSEcCtD
Cabergoline—Diarrhoea—Bupropion—obesity	6.5e-05	0.000621	CcSEcCtD
Cabergoline—Nausea—Sibutramine—obesity	6.47e-05	0.000619	CcSEcCtD
Cabergoline—Hypertension—Topiramate—obesity	6.4e-05	0.000612	CcSEcCtD
Cabergoline—Arthralgia—Topiramate—obesity	6.31e-05	0.000603	CcSEcCtD
Cabergoline—Anxiety—Topiramate—obesity	6.29e-05	0.000601	CcSEcCtD
Cabergoline—Dizziness—Bupropion—obesity	6.28e-05	0.0006	CcSEcCtD
Cabergoline—Discomfort—Topiramate—obesity	6.24e-05	0.000596	CcSEcCtD
Cabergoline—Dry mouth—Topiramate—obesity	6.18e-05	0.00059	CcSEcCtD
Cabergoline—Confusional state—Topiramate—obesity	6.1e-05	0.000583	CcSEcCtD
Cabergoline—Oedema—Topiramate—obesity	6.05e-05	0.000578	CcSEcCtD
Cabergoline—Vomiting—Bupropion—obesity	6.04e-05	0.000577	CcSEcCtD
Cabergoline—Rash—Bupropion—obesity	5.99e-05	0.000572	CcSEcCtD
Cabergoline—Dermatitis—Bupropion—obesity	5.99e-05	0.000572	CcSEcCtD
Cabergoline—Shock—Topiramate—obesity	5.96e-05	0.000569	CcSEcCtD
Cabergoline—Headache—Bupropion—obesity	5.95e-05	0.000569	CcSEcCtD
Cabergoline—Hyperhidrosis—Topiramate—obesity	5.85e-05	0.000559	CcSEcCtD
Cabergoline—Anorexia—Topiramate—obesity	5.77e-05	0.000551	CcSEcCtD
Cabergoline—Hypotension—Topiramate—obesity	5.66e-05	0.00054	CcSEcCtD
Cabergoline—Nausea—Bupropion—obesity	5.64e-05	0.000539	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Topiramate—obesity	5.52e-05	0.000527	CcSEcCtD
Cabergoline—Insomnia—Topiramate—obesity	5.48e-05	0.000523	CcSEcCtD
Cabergoline—Paraesthesia—Topiramate—obesity	5.44e-05	0.000519	CcSEcCtD
Cabergoline—Dyspnoea—Topiramate—obesity	5.4e-05	0.000516	CcSEcCtD
Cabergoline—Somnolence—Topiramate—obesity	5.38e-05	0.000514	CcSEcCtD
Cabergoline—Dyspepsia—Topiramate—obesity	5.33e-05	0.000509	CcSEcCtD
Cabergoline—Decreased appetite—Topiramate—obesity	5.26e-05	0.000503	CcSEcCtD
Cabergoline—Fatigue—Topiramate—obesity	5.22e-05	0.000499	CcSEcCtD
Cabergoline—Pain—Topiramate—obesity	5.18e-05	0.000495	CcSEcCtD
Cabergoline—Constipation—Topiramate—obesity	5.18e-05	0.000495	CcSEcCtD
Cabergoline—Feeling abnormal—Topiramate—obesity	4.99e-05	0.000477	CcSEcCtD
Cabergoline—Gastrointestinal pain—Topiramate—obesity	4.95e-05	0.000473	CcSEcCtD
Cabergoline—Abdominal pain—Topiramate—obesity	4.79e-05	0.000457	CcSEcCtD
Cabergoline—Hypersensitivity—Topiramate—obesity	4.46e-05	0.000426	CcSEcCtD
Cabergoline—Asthenia—Topiramate—obesity	4.34e-05	0.000415	CcSEcCtD
Cabergoline—Pruritus—Topiramate—obesity	4.28e-05	0.000409	CcSEcCtD
Cabergoline—Diarrhoea—Topiramate—obesity	4.14e-05	0.000396	CcSEcCtD
Cabergoline—Dizziness—Topiramate—obesity	4e-05	0.000382	CcSEcCtD
Cabergoline—Vomiting—Topiramate—obesity	3.85e-05	0.000368	CcSEcCtD
Cabergoline—Rash—Topiramate—obesity	3.82e-05	0.000365	CcSEcCtD
Cabergoline—Dermatitis—Topiramate—obesity	3.81e-05	0.000364	CcSEcCtD
Cabergoline—Headache—Topiramate—obesity	3.79e-05	0.000362	CcSEcCtD
Cabergoline—Nausea—Topiramate—obesity	3.6e-05	0.000344	CcSEcCtD
Cabergoline—ADRA2C—Signaling Pathways—PIK3CB—obesity	8.09e-07	7.68e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—obesity	8.09e-07	7.68e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—obesity	8.09e-07	7.68e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TGFB1—obesity	8.08e-07	7.68e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—FASN—obesity	8.08e-07	7.68e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MYC—obesity	8.05e-07	7.65e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—BCHE—obesity	8.05e-07	7.64e-06	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—obesity	8.04e-07	7.64e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	8.03e-07	7.63e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RHOA—obesity	8.03e-07	7.63e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TGFB1—obesity	8.03e-07	7.63e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SERPINE1—obesity	8.02e-07	7.62e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—obesity	7.99e-07	7.59e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL2—obesity	7.99e-07	7.59e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TYK2—obesity	7.97e-07	7.57e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—STAT3—obesity	7.97e-07	7.57e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PIK3CB—obesity	7.96e-07	7.56e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MTOR—obesity	7.96e-07	7.56e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PIK3R1—obesity	7.95e-07	7.55e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOS3—obesity	7.95e-07	7.55e-06	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—obesity	7.94e-07	7.54e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—obesity	7.91e-07	7.52e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RHOA—obesity	7.9e-07	7.51e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—obesity	7.9e-07	7.5e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MYC—obesity	7.88e-07	7.49e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TGFB1—obesity	7.86e-07	7.47e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PIK3CB—obesity	7.86e-07	7.46e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—obesity	7.85e-07	7.46e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT2—obesity	7.84e-07	7.45e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PIK3R1—obesity	7.82e-07	7.43e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOS3—obesity	7.82e-07	7.43e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—obesity	7.81e-07	7.42e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TYK2—obesity	7.8e-07	7.41e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—obesity	7.78e-07	7.4e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2E1—obesity	7.76e-07	7.38e-06	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—obesity	7.76e-07	7.37e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MYC—obesity	7.75e-07	7.37e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RHOA—obesity	7.74e-07	7.35e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TGFB1—obesity	7.73e-07	7.35e-06	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—obesity	7.72e-07	7.33e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NQO1—obesity	7.68e-07	7.29e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PIK3R1—obesity	7.66e-07	7.28e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOS3—obesity	7.66e-07	7.28e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—obesity	7.64e-07	7.26e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—obesity	7.6e-07	7.22e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MMP9—obesity	7.6e-07	7.22e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—PIK3CA—obesity	7.57e-07	7.2e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3CD—obesity	7.54e-07	7.16e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MMP9—obesity	7.53e-07	7.15e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—STAT3—obesity	7.51e-07	7.14e-06	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—obesity	7.51e-07	7.13e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	7.47e-07	7.09e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SERPINE1—obesity	7.45e-07	7.08e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—PIK3CA—obesity	7.45e-07	7.08e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MMP9—obesity	7.43e-07	7.06e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—STAT3—obesity	7.41e-07	7.04e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—STAT3—obesity	7.41e-07	7.04e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MYC—obesity	7.4e-07	7.03e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—obesity	7.39e-07	7.02e-06	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—obesity	7.39e-07	7.02e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK8—obesity	7.39e-07	7.02e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—obesity	7.38e-07	7.02e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—obesity	7.37e-07	7e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GCG—obesity	7.36e-07	6.99e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SLC2A4—obesity	7.36e-07	6.99e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MTOR—obesity	7.34e-07	6.97e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PIK3CB—obesity	7.34e-07	6.97e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK8—obesity	7.32e-07	6.95e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—obesity	7.3e-07	6.94e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—PIK3CA—obesity	7.3e-07	6.93e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—obesity	7.29e-07	6.92e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—obesity	7.27e-07	6.91e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—obesity	7.27e-07	6.9e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYCS—obesity	7.26e-07	6.9e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TYK2—obesity	7.25e-07	6.89e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—obesity	7.23e-07	6.87e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—obesity	7.23e-07	6.87e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MTOR—obesity	7.22e-07	6.86e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PIK3CB—obesity	7.22e-07	6.86e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—obesity	7.21e-07	6.85e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RHOA—obesity	7.19e-07	6.83e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GGT1—obesity	7.13e-07	6.77e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GOT1—obesity	7.13e-07	6.77e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3R1—obesity	7.12e-07	6.76e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—obesity	7.12e-07	6.76e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MTOR—obesity	7.07e-07	6.72e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PIK3CB—obesity	7.07e-07	6.72e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—obesity	7.07e-07	6.71e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—obesity	7.05e-07	6.69e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—obesity	7.03e-07	6.68e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—obesity	7.03e-07	6.68e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NCOA1—obesity	7.02e-07	6.67e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—obesity	7.01e-07	6.66e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MYC—obesity	6.98e-07	6.63e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—obesity	6.96e-07	6.62e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—obesity	6.92e-07	6.57e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—STK11—obesity	6.92e-07	6.57e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP19A1—obesity	6.92e-07	6.57e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MYC—obesity	6.89e-07	6.54e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MYC—obesity	6.89e-07	6.54e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—PIK3CA—obesity	6.88e-07	6.53e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—obesity	6.87e-07	6.53e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—obesity	6.87e-07	6.53e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—obesity	6.84e-07	6.5e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—PIK3CA—obesity	6.83e-07	6.49e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—obesity	6.82e-07	6.48e-06	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—obesity	6.81e-07	6.47e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—PIK3CA—obesity	6.78e-07	6.44e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—STAT3—obesity	6.75e-07	6.42e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—obesity	6.73e-07	6.39e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—obesity	6.71e-07	6.38e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—obesity	6.71e-07	6.37e-06	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—obesity	6.7e-07	6.37e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—STAT3—obesity	6.69e-07	6.36e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—PIK3CA—obesity	6.69e-07	6.36e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—STAT3—obesity	6.61e-07	6.28e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—obesity	6.6e-07	6.27e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—PIK3CA—obesity	6.58e-07	6.25e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MTOR—obesity	6.57e-07	6.24e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3CB—obesity	6.57e-07	6.24e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—obesity	6.56e-07	6.24e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—obesity	6.46e-07	6.14e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—STAT3—obesity	6.46e-07	6.14e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—COMT—obesity	6.43e-07	6.11e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—STAT3—obesity	6.43e-07	6.11e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—obesity	6.38e-07	6.06e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARGC1A—obesity	6.34e-07	6.03e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNB3—obesity	6.34e-07	6.03e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—obesity	6.31e-07	6e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—PIK3CA—obesity	6.28e-07	5.97e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—obesity	6.28e-07	5.96e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MYC—obesity	6.28e-07	5.96e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—obesity	6.26e-07	5.95e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—STAT3—obesity	6.25e-07	5.94e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MYC—obesity	6.22e-07	5.91e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—obesity	6.2e-07	5.89e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—obesity	6.2e-07	5.89e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—obesity	6.19e-07	5.88e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNAS—obesity	6.18e-07	5.87e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—STAT3—obesity	6.15e-07	5.84e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—obesity	6.15e-07	5.84e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MYC—obesity	6.14e-07	5.83e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—obesity	6.12e-07	5.82e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—obesity	6.1e-07	5.8e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—obesity	6.1e-07	5.79e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—obesity	6.09e-07	5.78e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—obesity	6.09e-07	5.78e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—obesity	6.05e-07	5.75e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOB—obesity	6.05e-07	5.75e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—obesity	6e-07	5.7e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MYC—obesity	6e-07	5.7e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—obesity	5.99e-07	5.69e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—obesity	5.98e-07	5.68e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MYC—obesity	5.97e-07	5.67e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—obesity	5.96e-07	5.66e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—obesity	5.96e-07	5.66e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—PIK3CA—obesity	5.93e-07	5.63e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—obesity	5.92e-07	5.63e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PIK3CA—obesity	5.9e-07	5.6e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—PIK3CA—obesity	5.85e-07	5.55e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—PIK3CA—obesity	5.85e-07	5.55e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—obesity	5.83e-07	5.54e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MYC—obesity	5.81e-07	5.52e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—obesity	5.79e-07	5.5e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LPL—obesity	5.77e-07	5.49e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MYC—obesity	5.72e-07	5.43e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—obesity	5.71e-07	5.43e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—obesity	5.7e-07	5.42e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—STAT3—obesity	5.67e-07	5.39e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—obesity	5.63e-07	5.35e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—obesity	5.62e-07	5.34e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—obesity	5.58e-07	5.3e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—STAT3—obesity	5.58e-07	5.3e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—obesity	5.56e-07	5.29e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—obesity	5.55e-07	5.28e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—obesity	5.54e-07	5.26e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CD36—obesity	5.49e-07	5.21e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—STAT3—obesity	5.46e-07	5.19e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—obesity	5.46e-07	5.19e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—obesity	5.38e-07	5.11e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—PIK3CA—obesity	5.33e-07	5.06e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—PIK3CA—obesity	5.28e-07	5.01e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MYC—obesity	5.27e-07	5.01e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—obesity	5.26e-07	4.99e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—obesity	5.25e-07	4.99e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PIK3CA—obesity	5.21e-07	4.95e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—obesity	5.2e-07	4.94e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MYC—obesity	5.19e-07	4.93e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—obesity	5.18e-07	4.92e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—obesity	5.18e-07	4.92e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—obesity	5.17e-07	4.91e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—obesity	5.13e-07	4.88e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARA—obesity	5.1e-07	4.85e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PIK3CA—obesity	5.1e-07	4.84e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MYC—obesity	5.08e-07	4.82e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—STAT3—obesity	5.08e-07	4.82e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PIK3CA—obesity	5.07e-07	4.82e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—obesity	5.07e-07	4.81e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—obesity	4.94e-07	4.69e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PIK3CA—obesity	4.93e-07	4.68e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PIK3CA—obesity	4.85e-07	4.61e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—obesity	4.84e-07	4.6e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—obesity	4.84e-07	4.6e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—obesity	4.82e-07	4.58e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAV1—obesity	4.8e-07	4.56e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PIK3CA—obesity	4.79e-07	4.55e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOA1—obesity	4.78e-07	4.55e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—obesity	4.78e-07	4.54e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—obesity	4.78e-07	4.54e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MYC—obesity	4.72e-07	4.48e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—obesity	4.72e-07	4.48e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—obesity	4.71e-07	4.47e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—obesity	4.67e-07	4.44e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—obesity	4.61e-07	4.38e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—obesity	4.51e-07	4.29e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—obesity	4.49e-07	4.26e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PIK3CA—obesity	4.47e-07	4.25e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PIK3CA—obesity	4.4e-07	4.18e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CG—obesity	4.37e-07	4.15e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—obesity	4.37e-07	4.15e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—obesity	4.35e-07	4.13e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—obesity	4.31e-07	4.1e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PIK3CA—obesity	4.31e-07	4.1e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—obesity	4.3e-07	4.08e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—obesity	4.26e-07	4.04e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—obesity	4.22e-07	4.01e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—obesity	4.16e-07	3.95e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—obesity	4.16e-07	3.95e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—obesity	4.14e-07	3.93e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INS—obesity	4.14e-07	3.93e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—obesity	4.03e-07	3.83e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3CA—obesity	4e-07	3.8e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—obesity	3.96e-07	3.77e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—obesity	3.96e-07	3.76e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—obesity	3.91e-07	3.72e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—obesity	3.9e-07	3.7e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CD—obesity	3.84e-07	3.65e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—obesity	3.82e-07	3.63e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—obesity	3.79e-07	3.6e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—obesity	3.65e-07	3.47e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—obesity	3.63e-07	3.45e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3R1—obesity	3.63e-07	3.45e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—obesity	3.6e-07	3.42e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—obesity	3.55e-07	3.37e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—obesity	3.52e-07	3.35e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CB—obesity	3.35e-07	3.18e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—obesity	3.32e-07	3.15e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—obesity	3.27e-07	3.11e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CA—obesity	2.04e-07	1.94e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—obesity	1.67e-07	1.58e-06	CbGpPWpGaD
